Home

Zucht Vorgänger Sizilien rituximab rtx Lindern Kalb Kondensator

Interrupting rituximab treatment in relapsing-remitting multiple sclerosis;  no evidence of rebound disease activity - Multiple Sclerosis and Related  Disorders
Interrupting rituximab treatment in relapsing-remitting multiple sclerosis; no evidence of rebound disease activity - Multiple Sclerosis and Related Disorders

specificity for rituximab (rtx) and infliximab (ifx) peptides of the... |  Download Scientific Diagram
specificity for rituximab (rtx) and infliximab (ifx) peptides of the... | Download Scientific Diagram

ANCA Response upon Rituximab or Cyclophosphamide in ANCA-associated  Vasculitis Patients - ACR Meeting Abstracts
ANCA Response upon Rituximab or Cyclophosphamide in ANCA-associated Vasculitis Patients - ACR Meeting Abstracts

Rituximab (RTX)-induces in vitro complement-dependent cytotoxicity... |  Download Scientific Diagram
Rituximab (RTX)-induces in vitro complement-dependent cytotoxicity... | Download Scientific Diagram

טוויטר \ ERA - European Renal Association בטוויטר: "Pierre Ronco. Rituximab  in membranous nephropathy. MENTOR-trial. Rtx is as effective as Cs in  inducing C/PR #ERAEDTA18 #RITUXIMAB #RtxGlomerulardisease  https://t.co/Ein148uebM"
טוויטר \ ERA - European Renal Association בטוויטר: "Pierre Ronco. Rituximab in membranous nephropathy. MENTOR-trial. Rtx is as effective as Cs in inducing C/PR #ERAEDTA18 #RITUXIMAB #RtxGlomerulardisease https://t.co/Ein148uebM"

Rituximab Versus Abatacept in Rheumatoid Arthritis Patients with an  Inadequate Response to Prior Biologic Therapy: A Retrospective,  Single-Center Study - ACR Meeting Abstracts
Rituximab Versus Abatacept in Rheumatoid Arthritis Patients with an Inadequate Response to Prior Biologic Therapy: A Retrospective, Single-Center Study - ACR Meeting Abstracts

Rituximab Therapy for Severe Refractory Chronic Henoch-Schönlein Purpura -  The Journal of Pediatrics
Rituximab Therapy for Severe Refractory Chronic Henoch-Schönlein Purpura - The Journal of Pediatrics

Rituximab-associated Vasculitis Flare: Incidence, Predictors, and Outcome |  The Journal of Rheumatology
Rituximab-associated Vasculitis Flare: Incidence, Predictors, and Outcome | The Journal of Rheumatology

Ex-Vivo Perfusion Mediated Delivery of Rituximab to Clear Latent  Epstein-Barr Virus - ATC Abstracts
Ex-Vivo Perfusion Mediated Delivery of Rituximab to Clear Latent Epstein-Barr Virus - ATC Abstracts

Rituximab (RTX) stimulation induces SHP-1 recruitment to CD16 z chain.... |  Download Scientific Diagram
Rituximab (RTX) stimulation induces SHP-1 recruitment to CD16 z chain.... | Download Scientific Diagram

Reconstitution of B cells after one cycle of rituximab (RTX) with... |  Download Scientific Diagram
Reconstitution of B cells after one cycle of rituximab (RTX) with... | Download Scientific Diagram

PV | RITUXAN® (rituximab) Dosing & Infusion Resources
PV | RITUXAN® (rituximab) Dosing & Infusion Resources

Level of rituximab (RTX) and B cells after initiation of RTX therapy in...  | Download Scientific Diagram
Level of rituximab (RTX) and B cells after initiation of RTX therapy in... | Download Scientific Diagram

Activatory and Inhibitory Fcγ Receptors Augment Rituximab-mediated  Internalization of CD20 Independent of Signaling via the Cytoplasmic  Domain* - Journal of Biological Chemistry
Activatory and Inhibitory Fcγ Receptors Augment Rituximab-mediated Internalization of CD20 Independent of Signaling via the Cytoplasmic Domain* - Journal of Biological Chemistry

Dosage regimen. Rituximab (RTX) and investigational drug (mycophenolate...  | Download Scientific Diagram
Dosage regimen. Rituximab (RTX) and investigational drug (mycophenolate... | Download Scientific Diagram

Rituximab (RTX) treatment correlates with significant attenuation of... |  Download Scientific Diagram
Rituximab (RTX) treatment correlates with significant attenuation of... | Download Scientific Diagram

Hypersialylation characterizes CLL cells resistant to rituximab (RTX)... |  Download Scientific Diagram
Hypersialylation characterizes CLL cells resistant to rituximab (RTX)... | Download Scientific Diagram

Figure 1 Relapse and rituximab historyThe figure shows rituximab (RTX)  treatment history as well as relapse history for 100 days prior to the  first RTX. - ppt download
Figure 1 Relapse and rituximab historyThe figure shows rituximab (RTX) treatment history as well as relapse history for 100 days prior to the first RTX. - ppt download

Increase in the density of CD20 improves the efficacy of rituximab (... |  Download Scientific Diagram
Increase in the density of CD20 improves the efficacy of rituximab (... | Download Scientific Diagram

Efficacy of Rituximab and Plasma Exchange in Antineutrophil Cytoplasmic  Antibody–Associated Vasculitis with Severe Kidney Disease | American  Society of Nephrology
Efficacy of Rituximab and Plasma Exchange in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis with Severe Kidney Disease | American Society of Nephrology

Successful rituximab treatment of granulomatosis with polyangiitis with  cranial neuropathies | Inflammation and Regeneration | Full Text
Successful rituximab treatment of granulomatosis with polyangiitis with cranial neuropathies | Inflammation and Regeneration | Full Text

Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based  biomarker analysis of the phase 4 R4RA randomized trial | Nature Medicine
Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial | Nature Medicine

Rituximab as Induction Therapy in Eosinophilic Granulomatosis with  Polyangiitis Refractory to Conventional Immunosuppressive Treatment: A  36-Month Follow-Up Analysis - The Journal of Allergy and Clinical  Immunology: In Practice
Rituximab as Induction Therapy in Eosinophilic Granulomatosis with Polyangiitis Refractory to Conventional Immunosuppressive Treatment: A 36-Month Follow-Up Analysis - The Journal of Allergy and Clinical Immunology: In Practice